More information about the study of Metformin

News about the anti-aging potential of Metformin, a drug currently used to treat type 2 diabetes, is popping up all over the internet. Details about the trial, expected to run 5-7 years, suggest that it will involve 3,000 participants between 70 and 80 years of age from various locations in the U.S.

It is important to clarify that the upcoming clinical trial is trying to “increase health span, not look for eternal life,” as stated by one of the trial’s advisors, Stephanie Lederman who is also Executive Director of American Federation for Aging Research.

click here to read full article